Terbutaline Sulphate + Guaiphenesin + Bromhexine HCl + MentholThird Party Manufacturing in India

Terbutaline Sulphate + Guaiphenesin + Bromhexine HCl + Menthol is a multi-ingredient expectorant combination designed for symptomatic relief of productive cough and chest congestion. Terbutaline Sulphate is a beta-2 adrenergic receptor agonist that works by relaxing the smooth muscles of the bronchial airways. It binds selectively to beta-2 receptors on bronchial smooth muscle, activating adenylate cyclase which increases intracellular cyclic AMP. This leads to bronchodilation, making it easier for the patient to breathe. Guaiphenesin is an expectorant that acts by increasing the volume and reducing the viscosity of bronchial secretions. It stimulates the gastric mucosa via a reflex arc that increases respiratory tract fluid output, making mucus thinner and easier to expectorate. Bromhexine HCl is a mucolytic agent that breaks down acid mucopolysaccharide fibres in the mucus structure, reducing sputum viscosity and facilitating cough clearance. Menthol provides a cooling sensation and acts as a mild local anaesthetic on the throat mucosa, helping to soothe irritation. Together, this combination addresses the four pillars of cough management: bronchodilation, mucus thinning, mucus breakdown, and symptomatic soothing.

Therapeutic Uses

Terbutaline Sulphate + Guaiphenesin + Bromhexine HCl + Menthol combination is prescribed for:

• Productive Cough Associated with Bronchitis: Helps clear excessive phlegm and mucus from the airways in acute and chronic bronchitis.
• Chronic Obstructive Pulmonary Disease (COPD): Provides symptomatic relief of cough and chest congestion in COPD patients.
• Asthma with Mucous Congestion: Bronchodilator action combined with expectorant-mucolytic activity addresses both bronchoconstriction and mucus accumulation.
• Upper Respiratory Tract Infections: Commonly used for cough associated with the common cold, influenza, and pharyngitis where mucus production is increased.
• Bronchiectasis: Helps in clearing thick secretions from dilated airways.

Why Manufacturers Choose This Combination

This four-drug combination expectorant is one of the highest-volume respiratory formulations manufactured in India. It is widely prescribed by general practitioners and paediatricians, making it a staple in PCD franchise catalogues. The syrup formulation is economical to produce and has a well-established supply chain for all four APIs. High demand from domestic and export markets, combined with multiple brand opportunities, makes it a consistently profitable molecule for third party manufacturers in India. This makes Terbutaline Sulphate + Guaiphenesin + Bromhexine HCl + Menthol one of the most sought-after combinations for PCD franchise and contract manufacturing operations.